Login / Signup

In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PET.

Anchal GhaiNikki FettigFrancesca FontanaJohn DiPersioMike RettigJulie O NealSamuel AchilefuKooresh I ShoghiMonica Shokeen
Published in: EJNMMI research (2021)
[64Cu]Cu-LLP2A is a promising tracer for timely in vivo assessment of therapeutic response in disseminated models of MM.
Keyphrases
  • multiple myeloma
  • positron emission tomography
  • pet imaging
  • aqueous solution
  • pet ct
  • metal organic framework
  • computed tomography